NRX Pharmaceuticals (NRXP) said Thursday that its Hope Therapeutics unit signed a $7.8 million term sheet with Universal Capital.
The proceeds will fund Hope's planned rollup of interventional psychiatry clinics, starting with the acquisitions of Dura Medical, Kadima and NeuroSpa, according to the company.
Hope expects to raise up to $10.3 million in capital from the proceeds of the term sheet and a previously announced investment.
Shares of NRX Pharmaceuticals were down 2% in recent trading.
Price: 2.23, Change: -0.04, Percent Change: -1.98
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。